Adverse Psychiatric Reactions to Modern Medication

References

• Ahlgren P. Myelography with metrizamide in the cervical region. Acta Radiologica 1977; 98–104, Supplement 355
   Google Scholar
• Ahmad S., Sheikh A. I., Meeran M. K. Disopyramide-induced acute psychosis. Chest 1979; 76: 712
   PubMed Web of Science ®Google Scholar
• Alkana R. L., Parker E. S., Cohen H. B., Birch H., Noble E. P. Reversal of ethanol intoxication in humans: an assessment of the efficacy of propranolol. Psychopharmacologia 1976; 51: 29–37
   PubMed Web of Science ®Google Scholar
• Ambrosino S. V. Depressive reactions associated with reserpine. New York State Medical Journal 1974; 74: 860–864
   PubMedGoogle Scholar
• Amidsen A., Schou M. Lithium. Side-effects of Drugs Annual Number 3, M. N. G. Dukes. Excerpta Medica, Amsterdam 1979; 22–25
   Google Scholar
• Australian Prescriber. Naproxen 1980; 4: 44
   Google Scholar
• Ayd F. J. Drug-induced depression: fact or fallacy?. New York State Journal of Medicine 1958; 58: 354–356
   PubMedGoogle Scholar
• Baastrup P. C., Hollnagel P., Sorensen R., Schou M. Adverse reactions in treatment with lithium carbonate and haloperidol. Journal of the American Medical Association 1976; 236: 2645–2646
   PubMed Web of Science ®Google Scholar
• Bailey E. V., Stone T. W. The mechanism of amantadine in parkinsonism: a review. Archives Internationales de Pharmacodynamie et Thérapie 1975; 216: 246–262
   PubMedGoogle Scholar
• Baldessarini R. J., Lipinski J. Definition of ‘dementia’ with haloperidol. New England Journal of Medicine 1976; 295: 452
   Google Scholar
• Baloch N. Steroid psychosis: a case report. British Journal of Psychiatry 1974; 124: 545–546
   PubMed Web of Science ®Google Scholar
• Bant W. Diazepam withdrawal symptoms. British Medical Journal 1975; 4: 285
   PubMedGoogle Scholar
• Barbeau A. Long-term side-effects of L-dopa. Lancet 1971; 1: 395
   PubMed Web of Science ®Google Scholar
• Barnhart C., Bowden C. L. Toxic psychosis with cimetidine. American Journal of Psychiatry 1979; 136: 725–726
   Google Scholar
• Baumgartner G., Gavel M. J., Kaeser H. E., Pallis C. A., Rose F. C., Schaumberg H. H., Thomas P. K., Wadia N. H. Neuro-toxicity of halogenated hydroxyquinolines: clinical analysis of cases reported outside Japan. Journal of Neurology, Neurosurgery and Psychiatry 1979; 42: 1073–1085
   PubMed Web of Science ®Google Scholar
• Beeley A. Errors and misconceptions in drug prescribing. Journal of the Royal College of Physicians of London 1980; 14: 58–64
   Google Scholar
• Behrman S. Mutism induced by phenothiazines. British Journal of Psychiatry 1972; 121: 599–604
   Google Scholar
• Bellair G. H., Smith T. W., Abelmann H. W., Harper E., Hood W. B. Digitalis intoxication. New England Journal of Medicine 1971; 28: 989–997
   Google Scholar
• Berry K., Garlett E. L., Bellet S., Gifter V. I. Use of pronestyl in treatment of ectopic rhythms. American Journal of Medicine 1951; 11: 431–441
   PubMed Web of Science ®Google Scholar
• Blazer D. G., Petrie W. M., Wilson W. P. Affective psychoses following renal transplant. Diseases of the Nervous System 1976; 37: 663–667
   PubMedGoogle Scholar
• Blum A. Patients at risk of developing severe side-effects from depot fluphenazine treatment. American Journal of Psychiatry 1980; 137: 254–255
   Google Scholar
• Borison R. L. Amantadine-induced psychosis in a geriatric patient with renal disease. American Journal of Psychiatry 1979; 136: 111–112
   Google Scholar
• Boston Collaborative Drug Surveillance Programme. Side-effects of non-psychiatric drugs. Seminars in Psychiatry 1971; 3: 406–420
   Google Scholar
• Bound D., Greer S. Psychiatric symptoms after dipipanone. Lancet 1978; 2: 480
   Google Scholar
• Boyd A. E., Reichlin S., Turksoy N. Galactorrhoea-amenorrhea syndrome: diagnosis and therapy. Annals of Internal Medicine 1977; 87: 165–175
   PubMed Web of Science ®Google Scholar
• Brogden R. H., Speight T. N., Avery G. S. Baclofen: a preliminary report on pharmacological properties and therapeutic efficacy in spasticity. Drugs 1974; 8: 1–14
   PubMed Web of Science ®Google Scholar
• Bunney W. E., Davis J. M. Norepinephrine in depressive reactions. Archives of General Psychiatry 1965; 13: 483–494
   PubMed Web of Science ®Google Scholar
• Byrd G. J., Kane F. J. Persistent psychotic phenomena following one dose of pentazocine. Texas Medicine 1976; 72: 68–69
   Google Scholar
• Calne D. B., Plotkin C., Williams A. C., Nutt J. G., Neophytides A., Teychenne P. F. Long-term treatment of parkinsonism with bromocriptine. Lancet 1978; 1: 735–738
   PubMed Web of Science ®Google Scholar
• Campbell N. P. S., Kelly J. G., Shanks K. G., Chaturvedi N. C., Storey G. E., Partridge J. F. Mexiletine in the management of ventricular dysrhythmias. Lancet 1973; 2: 404–407
   Google Scholar
• Carney M. W. P. Serum folate values in 423 psychiatric patients. British Medical Journal 1967; 4: 512–516
   PubMedGoogle Scholar
• Carney M. W. P. Paranoid psychosis with indomethacin. British Medical Journal 1977; 2: 994–995
   PubMed Web of Science ®Google Scholar
• Carney M. W. P., Harris M. Psychiatric disorder and diethylpropion hydrochloride. Pracitioner 1979; 223: 549–552
   PubMedGoogle Scholar
• Carney M. W. P., Sheffield B. F. Association of subnormal serum folate and vitamin B12 values and effects of replacement therapy. Journal of Nervous and Mental Disease 1970; 150: 404–412
   PubMed Web of Science ®Google Scholar
• Carney M. W. P., Sheffield B. F. Forty-two months of experience of flupenthixol in the treatment of schizophrenia. Current Medical Research and Opinion 1975; 3: 447–452
   Google Scholar
• Cass J., Alexander L., Enders M. Complications of corticotropin therapy in multiple scierosis. Journal of American Medical Association 1966; 197: 173–178
   PubMed Web of Science ®Google Scholar
• Church G., Schamroth L., Schwartz N. L., Marriott H. J. Deliberate digitalis intoxication: a comparison of the toxic effects of four glycoside preparations. Annals of Internal Medicine 1962; 57: 946–956
   PubMed Web of Science ®Google Scholar
• Clark L. D., Quarton G. C., Cobb S., Bauer W. Further observations on mental disturbances associated with cortisone and A.C.T.H. therapy. New England Journal of Medicine 1953; 249: 178–183
   PubMedGoogle Scholar
• Clein L. J., Benady D. R. Case of diethylpropion addiction. British Medical Journal 1962; 2: 456
   PubMedGoogle Scholar
• Cohen W. J., Cohen N. H. Lithium carbonate, haloperidol and irreversible brain damage. Journal of the American Medical Association 1974; 230: 1283–1287
   PubMed Web of Science ®Google Scholar
• Connell P. H. Amphetamine Psychosis. Chapman and Hall, London 1958
   Google Scholar
• Coursey C. E. The psychotomimetic side-effects of pentazocine. Drug Intelligence and Pharmacy 1978; 12: 341–346
   Google Scholar
• Csillag E. R., Landauer A. A. Alleged hallucinogenic effect of a toxic overdose of an antihistamine preparation. Medical Journal of Australia 1973; 1: 653–654
   Google Scholar
• Cutting J. Physical illness and psychosis. British Journal of Psychiatry 1980; 136: 109–119
   PubMed Web of Science ®Google Scholar
• Davies R. H., Tucker G. J., Harrow M., Detre T. P. Confusional episodes and antidepressant medication. American Journal of Psychiatry 1971; 128: 95–99
   PubMed Web of Science ®Google Scholar
• Davis K. L., Hollister L. E., Berger P. A. Baclofen in schizophrenia. Lancet 1976; 1: 1245
   Google Scholar
• Davison W. Neurological and mental disturbances due to drugs. Age and Ageing 1978; 7: 119–127, Supplement
   Google Scholar
• de Bard M. L. Diazepam withdrawal syndrome. American Journal of Psychiatry 1979; 136: 104–105
   PubMed Web of Science ®Google Scholar
• de Nosaquo N. The hallucinatory effect of pentazocine. Journal of the American Medical Association 1969; 210: 502
   PubMed Web of Science ®Google Scholar
• Drew J. Concerning the side-effects of anti-malarial drugs used in the extended treatment of rheumatic disease. Medical Journal of Australia 1962; 2: 618–620
   Web of Science ®Google Scholar
• Dysken M. W., Chan C. H. Diazepam withdrawal psychosis. American Journal of Psychiatry 1977; 134: 573
   PubMed Web of Science ®Google Scholar
• Edison G. R. Hallucinations associated with pentazocine. New England Journal of Medicine 1969; 281: 447–448
   PubMedGoogle Scholar
• Editorial. Methyldopa and hypertension. British Medical Journal 1966; 1: 119
   Google Scholar
• Editorial. Depression and oral contraceptives. British Medical Journal 1970; 4: 127–128
   Google Scholar
• Editorial. Antidepressants and histamine. Lancet 1978; 1: 808
   Google Scholar
• Evans J. G., Jarvis E. H. Nitrazepam and the elderly. British Medical Journal 1972; 4: 487
   PubMed Web of Science ®Google Scholar
• Evans L. E. J. Psychological effects caused by drugs in overdose. Drugs 1980; 19: 220–242
   Google Scholar
• Erikssen J. Atropine psychosis. Lancet 1969; I: 53–54
   Google Scholar
• Falk R. H., Nisbet P. A., Gray T. J. Mental distress in patients on disopyramide. Lancet 1977; 1: 858–859
   Google Scholar
• Falk W. E., Mahnke M. W., Poskanzer C. Lithium prophylaxis of corticotropin-induced psychosis. Journal of the American Medical Association 1979; 241: 1011–1012
   PubMed Web of Science ®Google Scholar
• Flemenbaum A., Gunby B. Ethchlorvynol (placidyl) abuse and withdrawal. Diseases of the Nervous System 1971; 32: 188–192
   Google Scholar
• Fleminger R. Visual hallucinations and illusions with propranolol. British Medical Journal 1978; 1: 1182
   PubMedGoogle Scholar
• Flind A. C., Jones D. R. Mental confusion with cimetidine. Lancet 1979; 1: 379
   Google Scholar
• Frazer H. S., Carr A. C. Propranolol psychosis. British Journal of Psychiatry 1976; 129: 508–512
   Google Scholar
• Freis E. D. Mental depression in hypertensive patients treated for long periods with large doses of reserpine. New England Journal of Medicine 1975; 251: 1006
   Google Scholar
• Fruensgaard K. Withdrawal psychosis: a study of 30 consecutive cases. Acta Psychiatrica Scandinavica 1976; 53: 105–118
   PubMed Web of Science ®Google Scholar
• Fullerton A. G., Boardman R. H. Side-effects of Tofranil. Lancet 1959; 1: 1209–1210
   Google Scholar
• Gaind R. Fenfluramine (Ponderax) in the treatment of obese psychiatric outpatients. British Journal of Psychiatry 1969; 115: 963–964
   PubMed Web of Science ®Google Scholar
• Gelenberg A. J., Mandel M. R. Catatonic reactions to high potency neuroleptic drugs. Archives of General Psychiatry 1977; 34: 947–980
   PubMed Web of Science ®Google Scholar
• Gershon E. S., Goldstein R. E., Moss A. J., Van Kainen D. P. Psychosis with ordinary doses of propranolol. Annals of Internal Medicine 1979; 90: 938–939
   PubMed Web of Science ®Google Scholar
• Gifford S., Murawski B. J., Kline N. S., Sachar R. E. An unusual adverse reaction to self-medication with prednisone. International Journal of Psychiatry in Medicine 1976; 7: 97–122
   Google Scholar
• Gilbert G. J. Quinidine dementia. Journal of the American Medical Association 1977; 237: 2093–2094
   Google Scholar
• Gonsette R. E. Cervical myelography with metrizamide by suboccipital puncture. Acta Radiologica 1977; 121–126, Supplement 355
   Google Scholar
• Good M. I., Shader R. I. Behavioural toxicity and equivocal suicide associated with chloroquine and its derivatives. American Journal of Psychiatry 1977; 134: 798–801
   PubMed Web of Science ®Google Scholar
• Goodwin F. K. Behavioural effects of L-dopa in man. Psychiatric Complications of Medical Drugs, R. I. Shader. Raven Press, New York 1972; 149–174
   Google Scholar
• Goodwin F. K., Ebert M. H., Bunney W. H. Mental effects of reserpine in man: a review. Psychiatric Complications of Medical Drugs, R. I. Shader. Raven Press, New York 1972; 73–102
   Google Scholar
• Gott P. H. Cyclizine toxicity: intentional use of a proprietary antihistamine. New England Journal of Medicine 1968; 279: 596
   Web of Science ®Google Scholar
• Gotz V. Paranoid psychosis with indomethacin. British Medical Journal 1978; 1: 49
   Google Scholar
• Granville-Grossman K. G. Recent Advances in Clinical Psychiatry. J. and A. Churchill, London 1971; 197–198, 202–204
   Google Scholar
• Greenblatt D. T., Shader R. I. Digitalis toxicity. Psychiatric Complications of Medical Drugs, R. I. Shader. Raven Press, New York 1972; 25–47
   Google Scholar
• Greenblatt D. J., Allen M. D., Shader R. I. Toxicity of high dose flurazepam in the elderly. Clinical Pharamacology and Therapeutics 1977; 21: 355–361
   PubMed Web of Science ®Google Scholar
• Greer H. D., Ward H. P., Corborin K. B. Chronic salicylate intoxication in adults. Journal of the American Medical Association 1965; 193: 555–558
   PubMed Web of Science ®Google Scholar
• Grimson T. A. Reactions to cimetidine. Lancet 1977; 1: 858
   PubMedGoogle Scholar
• Gupta V. P., Ehrlich G. E. Organic brain syndromes in rheumatoid arthritis following corticosteroid withdrawal. Arthritis and Rheumatism 1976; 19: 1333–1338
   Google Scholar
• Hall R. C. W., Popkin M. K., Stickney S. K., Gardner E. R. Presentation of the steroid psychoses. Journal of Nervous and Mental Disease 1979; 167: 229–236
   PubMed Web of Science ®Google Scholar
• Hanna S. M. A case of oxazepam (Serenid) dependence. British Journal of Psychiatry 1972; 120: 443–445
   PubMed Web of Science ®Google Scholar
• Hausner R. S. Amantadine-associated recurrence of psychosis. American Journal of Psychiatry 1980; 137: 240–241
   Google Scholar
• Harper R. W., Knothe B. A. W.C. Coloured lilliputian hallucinations with amantadine. Medical Journal of Australia 1973; 1: 444–445
   PubMed Web of Science ®Google Scholar
• Harris B., Harper M. Psychosis after dextropropoxyphene. Lancet 1979; 2: 743
   Google Scholar
• Harris D., Richards D. A. Beta-blockers in the treatment of hypertension. British Medical Journal 1978; 2: 894
   Google Scholar
• Hawkins D. J. Acute organic brain syndrome, psychosis with methyldopa therapy. Missouri Medicine 1976; 73: 476–481
   Google Scholar
• Helson L., Duque L. Acute brain syndrome after propranolol. Lancet 1978; 1: 98
   Google Scholar
• Herridge C. F., A'Brook M. F. Ephedrine psychosis. British Medical Journal 1968; 2: 160
   PubMed Web of Science ®Google Scholar
• Heston L. L., Hastings D. Psychosis with withdrawal from ethchlorvynol. American Journal of Psychiatry 1980; 137: 249–250
   PubMed Web of Science ®Google Scholar
• Herzberg B. N., Johnson A. L., Brown S. Depressive symptoms and oral contraceptives. British Medical Journal 1970; 4: 142–145
   PubMed Web of Science ®Google Scholar
• Herzberg B. N., Draper K. C., Johnson A. L., Nichol G. C. Oral contraceptives, depression and libido. British Medical Journal 1971; 3: 495–500
   PubMedGoogle Scholar
• Hollister L. E. Withdrawal from benzodiazepine therapy. Journal of the American Medical Association 1977; 237: 1432
   Web of Science ®Google Scholar
• Holmes J. M. Cerebral manifestations of vitamin B12 deficiency. British Medical Journal 1956; 2: 1394–1398
   PubMedGoogle Scholar
• Howe J. G. Lorazepam withdrawal seizures. British Medical Journal 1980; 1: 1163–1164
   Google Scholar
• Hua A. A. S., Kalowski S., Whitworth J. A., Kincaid-Smith P. Acebutalol in mild to moderate hypertension. Medical Journal of Australia 1980; 1: 226–228
   Google Scholar
• Hudson H. S., Walker H. I. Withdrawal symptoms following ethchlorvynol (Placidyl) dependence. American Journal of Psychiatry 1961; 118: 361
   PubMed Web of Science ®Google Scholar
• Hunter K. R., Lawrence D. R., Shaw K. M., Stern G. M. Sustained levodopa therapy in parkinsonism. Lancet 1973; 2: 929–931
   Google Scholar
• Hunter R., Matthews D. M. Mental symptoms in vitamin B12 deficiency. Lancet 1965; 2: 738
   Google Scholar
• Imlah M. W. Unusual effect of fenfluramine. British Medical Journal 1970; 2: 178
   Google Scholar
• Innes J. A., Watson M. L., Munro J. F., Stoddart M., Campbell D. B. Plasma fenfluramine weight loss and side-effects. British Medical Journal 1977; 2: 1322–1324
   PubMed Web of Science ®Google Scholar
• Jackson S. L. O. Psychosis with isoniazid. British Medical Journal 1957; 2: 743–746
   Google Scholar
• Janowsky D. S., El Yousef K., Davis M., Sekerke H. J. A cholinergic-adrenergic hypothesis of mania and depression. Lancet 1972; 2: 632–633
   PubMed Web of Science ®Google Scholar
• Jefferson J. W. The case of the numb testicles. Journal of Clinical Psychiatry 1977; 38: 749–751
   Google Scholar
• Jefferson J. W. Central nervous system toxicity of cimetidine: a case of depression. American Journal of Psychiatry 1979; 136: 346
   Google Scholar
• Jefferson J. W., Greist J. H. A Primer of Lithium Therapy. Williams, Wilkins, Baltimore 1977
   Google Scholar
• Jenkins R. B., Groh R. H. Mental symptoms in parkinsonian patients treated with L-dopa. Lancet 1970; 2: 177–180
   PubMed Web of Science ®Google Scholar
• Johnson P., Kitchin A. H., Lawther C. P., Turner R. W. Treatment of hypertension with methyldopa. British Medical Journal 1966; 1: 133
   PubMed Web of Science ®Google Scholar
• Johnson J., Bailey S. Cimetidine and psychiatric complications. British Journal of Psychiatry 1979; 134: 315–316
   Google Scholar
• Jones H. S. Diethylpropion dependence. Medical Journal of Australia 1968; 1: 267
   PubMedGoogle Scholar
• Jones I. H., Stevenson J., Jordan A., Connell N. M., Hetherington H. D. G., Gibney G. N. Pheniramine as an hallucinogen. Medical Journal of Australia 1973; 1: 382–386
   Google Scholar
• Kane F. J., Treadaway R., Ewing J. A. Emotional changes associated with oral contraceptives in female psychiatric patients. Comprehensive Psychiatry 1969; 10: 16–30
   PubMed Web of Science ®Google Scholar
• Kingston P. Tetrabenazine for involuntary movement disorders. Medical Journal of Australia 1979; 1: 628–629
   PubMed Web of Science ®Google Scholar
• Kinnell H. G., Webb A. Confusion associated with cimetidine. British Medical Journal 1979; 2: 1438
   Google Scholar
• Klein D. F. Visual hallucinations with imipramine. American Journal of Psychiatry 1965; 121: 911–914
   PubMed Web of Science ®Google Scholar
• Kuenssberg E. V. Diethylpropion. British Medical Journal 1962; 2: 729–730
   Google Scholar
• Knight A., Okasha N. S., Salik N. A., Hirsch S. R. Depression and extrapyramidal symptoms and clinical effects with a trial of fluphenazine versus flupenthixol. British Journal of Psychiatry 1979; 135: 515–523
   PubMedGoogle Scholar
• Korolenko C. P., Yevseyeva T. A., Volkov P. B. Data for a comparative account of toxic psychoses of various aetiologies. British Journal of Psychiatry 1969; 115: 273–279
   Google Scholar
• Korsgaard S. Baclofen (Lioresal) in the treatment of neuroleptic-induced tardive dyskinesia. Acta Psychiatrica Scandinavica 1976; 54: 17–24
   PubMed Web of Science ®Google Scholar
• Kurland M. L. Organic brain syndrome with propranolol. New England Journal of Medicine 1979; 300: 366
   Google Scholar
• Kutner S. J., Brown W. L. Depression and contraception. Journal of Nervous and Mental Disease 1972; 155: 153–162
   PubMed Web of Science ®Google Scholar
• Learoyd B. M. Psychotropic drugs in the elderly patient. Medical Journal of Australia 1972; 1: 1131–1133
   PubMedGoogle Scholar
• Lees A. J., Clarke C. R. A., Harrison M. J. Hallucinations after withdrawal of baclofen. Lancet 1977; 1: 858
   PubMedGoogle Scholar
• Leeton J. Depression induced by oral contraceptives and the role of vitamin B6 in its management. Australian and New Zealand Journal of Psychiatry 1974; 8: 85–88
   PubMed Web of Science ®Google Scholar
• Levin A. The non-medical misuse of fenfluramine by drug dependent South Africans. Postgraduate Medical Journal 1975; 51: 186–188, Supplement 1
   PubMed Web of Science ®Google Scholar
• Lewis A. J., Fleminger J. J. The psychiatric risk from corticotrophin and cortisone. Lancet 1954; 1: 383–386
   Google Scholar
• Lewis A., Hoghughi M. An evaluation of depression as a side-effect of oral contraceptives. British Journal of Psychiatry 1969; 115: 697–701
   PubMedGoogle Scholar
• Liddon S. C., Satran R. Disulfiram (Antabuse) psychosis. American Journal of Psychiatry 1967; 123: 1284
   PubMed Web of Science ®Google Scholar
• Lieberman A. N., Gopinathan G., Estey E., Kupersmith M., Goodgold A., Goldstein M. Lergotrile in Parkinson's disease: further studies. Neurology 1979; 29: 267–272
   Google Scholar
• Linnoila A. M., Mattila M. J., Kitchell B. S. Drug interactions with alcohol. Drugs 1979; 18: 299–311
   PubMed Web of Science ®Google Scholar
• Loudon J. B., Waring H. Toxic reactions to lithium and haloperidol. Lancet 1976; 2: 1088
   PubMed Web of Science ®Google Scholar
• Malek-Ahmadi P., Behrman P. J. Depressive syndrome induced by oral contraceptives. Diseases of the Nervous System 1976; 37: 406–408
   Google Scholar
• Martin E. W., Martin R. Drug-alcohol interactions. Hazards of Medication, E. W. Martin, R. Martin. J. B. Lippincott, Philadelphia 1971; 430–439
   Google Scholar
• McClellan D. L. The suppression of involuntary movements with tetrabenazine. Scottish Medical Journal 1972; 17: 367–370
   Google Scholar
• McClellan D. L., Chalmers R. J., Johnson A. H. A double-blind trial of tetrabenazine, thiopropazate and placebo in patients with chorea. Lancet 1974; 1: 104–107
   Google Scholar
• McClelland H. A. Textbook of Adverse Drug Reactions, D. M. Davis. Oxford university Press, Oxford 1977; 335–353
   Google Scholar
• McCrum I. D., Guidry J. R. Procainamide-induced psychosis. Journal of the American Medical Association 1978; 240: 1265–1266
   Google Scholar
• McMillen M. A., Ambis D., Siegal J. H. Cimetidine and mental confusion. New England Journal of Medicine 1978; 298: 284–285
   Google Scholar
• Medical Letter on Drugs and Therapeutics. Antabuse 1980; 22: 1–2
   Google Scholar
• Menzies-Gow N. Cimetidine and mental confusion. Lancet 1977; 2: 928
   Google Scholar
• Millac P., Hasan I., Espir M. L. E., Slyfield D. G. Amantadine in Parkinson's disease. Lancet 1970; 1: 464
   Google Scholar
• Miller R. R. Meperidine hydrochloride. Drug Effects on Hospitalized Patients, R. R. Miller, D. J. Greenblatt. John Wiley and Sons, New York 1976; 144–148
   Google Scholar
• Miller R. R., Greenblatt D. J. Drug Effects on Hospitalized Patients. John Wiley and Sons, New York 1976
   Google Scholar
• Muller J. C., Pryor W. W., Gibbons J. E., Orgain E. S. Depression and anxiety occurring during rawolfia therapy. Journal of the American Medical Association 1955; 159: 839
   Google Scholar
• Mumenthaler M., Kaeser A. J., Meyer A., Hess T. Transient global amnesia after clioquinol. Journal of Neurology, Neurosurgery and Psychiatry 1979; 42: 1084–1090
   PubMedGoogle Scholar
• Murray R. M., Greene J. G., Adams J. H. Analgesic abuse and dementia. Lancet 1971; 2: 242–245
   PubMed Web of Science ®Google Scholar
• Meyler L., Herxheimer A. Side-effects of Drugs. Excerpta Medica, Amsterdam 1972; Volume 7
   Google Scholar
• Meyler's Side-Effects of Drugs, M. N. G. Dukes. Excerpta Medica, Amsterdam 1975; Volume 8
   Google Scholar
• Meyler's Side-Effects of Drugs Annual, M. N. G. Dukes. Excerpta Medica, Amsterdam 1977, 1978, 1979
   Google Scholar
• Nelson J. C., Bowers N. B., Sweeney P. R. Exacerbation of psychosis by tricyclic antidepressants in delusional depression. American Journal of Psychiatry 1979; 136/4B: 574–576
   Google Scholar
• Nelson P. G. Cimetidine and mental confusion. Lancet 1977; 1: 928
   Google Scholar
• New Zealand Hypertension Study Group. Initial experiences with prasozin in New Zealand. Medical Journal of Australia 1977; 23–26, Supplement I
   Google Scholar
• Nies A. S. Clinical pharmacology of antihypertensive drugs. Medical Clinics of North America 1977; 61: 675–698
   Google Scholar
• Nigro S. A. Toxic psychosis due to diphenhydramine hydrochloride (Benadryl). Journal of the American Medical Association 1968; 203: 301–302
   PubMed Web of Science ®Google Scholar
• Nillson A., Jacobson L., Ingemansson C-A. Side-effects of an oral contraceptive with particular attention to mental symptoms and sexual adaptation. Acta Obstetrica and Gynaecologica Scandinavica 1967; 46: 537–556
   Google Scholar
• Novenius G., Widerlov E., Lonnerholm G. Phenylpropanolamine and mental disturbances. Lancet 1979; 2: 1367–1368
   Google Scholar
• O'Brien W. M. Indomethacin: a survey of clinical trials. Clinical Pharmacology and Therapeutics 1968; 9: 94–107
   PubMed Web of Science ®Google Scholar
• Oswald I. Fenfluramine and psychosis. British Medical Journal 1974; 4: 103
   Google Scholar
• Ovesen L. Vitamin deficiencies and drugs. Drugs 1979; 18: 278–298
   PubMedGoogle Scholar
• Parkes J. D. Bromocriptine in the treatment of parkinsonism. Drugs 1979; 17: 365–382
   PubMed Web of Science ®Google Scholar
• Parry D. L., Rush J. Oral contraceptives and depressive symptomatology. Comprehensive Psychiatry 1979; 20: 347–358
   PubMed Web of Science ®Google Scholar
• Paykel E. S., Coppen A. Psychopharmacology of Affective Disorders. Oxford University Press, London 1979
   Google Scholar
• Pearlman C. A. Manic behaviour with L-dopa. New England Journal of Medicine 1971; 285: 1326
   Google Scholar
• Petite J. P., Bloch F. Syndrome dépressif au cours du traitement par cimétidine. Nouvelle Presse Medicale 1979; 8: 1260
   Google Scholar
• Peturson J. Diethylpropion and paranoid psychosis. Australian and New Zealand Journal of Psychiatry 1979; 13: 67–68
   Google Scholar
• Pevnick J. S., Jasinki D. R., Haertzen C. A. Abrupt withdrawal from therapeutically administered diazepam. Archives of General Psychiatry 1978; 35: 995–998
   PubMed Web of Science ®Google Scholar
• Pinto O. de S., Polikar M., Debono G. Results of international clinical trial of Lioresal. Postgraduate Medical Journal October, 1972; 48: 18–23, Supplement
   Google Scholar
• Postama T. W., Van Tillburg W. Visual hallucinations and delirium during treatment with amantadine (Symmetrel). Journal of the American Geriatric Society 1975; 23: 212–215
   Google Scholar
• Preskorn S. H., Denner L. E. Benzoidiazepines and withdrawal psychosis. Journal of the American Medical Association 1977; 237: 36–38
   PubMed Web of Science ®Google Scholar
• Rampling D. Aggression: a paradoxical response to tricyclic antidepressants. American Journal of Psychiatry 1978; 135: 117–118
   Google Scholar
• Reisberg B. Catatonia associated with disulfiram therapy. Journal of Nervous and Mental Disease 1978; 166: 607–609
   Google Scholar
• Restak R. M. Pseudotumor cerebri, psychosis and hypervitaminosis A. Journal of Nervous and Mental Disease 1972; 155: 72–75
   Google Scholar
• Reynolds E. H. Chronic anti-epileptic toxicity. Epilepsia 1975; 16: 319–352
   PubMed Web of Science ®Google Scholar
• Reynolds E. H., Preece J. M., Bailey J., Coppen A. Folate deficiency in depressive illness. British Journal of Psychiatry 1970; 117: 287–292
   PubMed Web of Science ®Google Scholar
• Robinson B. F. Drugs acting on the cardiovascular system. Meyler's Side-effects of Drugs, M. N. G. Dukes. Excerpta Medica, Amsterdam 1975; Volume 8: 428–460
   Google Scholar
• Robinson R. G. Indomethacin in rheumatic disease: a reassessment. Medical Journal of Australia 1966; 1: 971–972
   Google Scholar
• Rosenfield A. A. Depression and psychotic regression following prolonged methylphenidate use and withdrawal: case report. American Journal of Psychiatry 1979; 136: 226–228
   Google Scholar
• Ross R. R. Use of pyridoxine hydrochloride to prevent isoniazid toxicity. Journal of the American Medical Association 1958; 168: 273–275
   Google Scholar
• Routledge P. A. Adverse reactions to drug withdrawal. Adverse Drug Reaction Bulletin 1977; 47: 236–239
   Google Scholar
• Royal College of General Practitioners. Oral Contraceptives and Health. Pitman Medical, Manchester 1974
   Google Scholar
• Roxanas M. G., Spalding J. Ephedrine abuse psychosis. Medical Journal of Australia 1977; 2: 639–640
   PubMed Web of Science ®Google Scholar
• Ryback R. S., Schwab R. S. Manic response to levodopa therapy. New England Journal of Medicine 1971; 255: 788–789
   Google Scholar
• Salamanthan G. L., Gershon S. Imipramine withdrawal: an akathesia-like syndrome. American Journal of Psychiatry 1973; 130: 1286–1287
   Google Scholar
• Santos A. B., McCurdy L. Delirium after abrupt withdrawal from doxepin. American Journal of Psychiatry 1980; 137: 239–240
   PubMedGoogle Scholar
• Schentag J. J., Calleri G., Rose J. Q., Serra F. B., DeGlopper E., Benhard H. Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusion. Lancet 1979; 1: 177–181
   PubMed Web of Science ®Google Scholar
• Schildkraut J. J. The catecholamine hypothesis of affective disorder: a review of supporting evidence. American Journal of Psychiatry 1965; 122: 509–522
   PubMed Web of Science ®Google Scholar
• Schroeder H. A., Perry H. M. Psychosis apparently produced by reserpine. Journal of the American Medical Association 1955; 159: 839–840
   Google Scholar
• Schwab R. S., England A. C., Poskanzer D. C., Young R. R. Amantadine in the treatment of Parkinson's disease. Journal of the American Medical Association 1969; 208: 1168–1170
   PubMed Web of Science ®Google Scholar
• Senby M., Angrist B., Lieberman A. Mental disturbances during bromocriptine and lergotrile treatment of Parkinson's disease. American Journal of Psychiatry 1978; 135: 1227–1229
   Google Scholar
• Shader R. I. Psychiatric Complications of Medical Drugs. Raven Press, New York 1972
   Google Scholar
• Shannon P. J., Leonard D., Kidson M. A. Fenfluramine and psychosis. British Medical Journal 1974; 3: 576
   Google Scholar
• Shatan C. Withdrawal symptoms from abrupt termination of imipramine. Canadian Psychiatric Association Journal 1966; 11: 150–158, Special Supplement
   Google Scholar
• Silverstone T., Turner P. Drug Treatment in Psychiatry. Routledge and Kegan Paul, London 1974
   Google Scholar
• Simpson F. O., Waal-Manning H. J. Hypertension and depression. Journal of the Royal College of Physicians of London 1971; 6: 14–24
   PubMedGoogle Scholar
• Siomopoulos V. Amphetamine psychosis: overview and an hypothesis. Diseases of the Nervous System 1975; 36: 336–339
   Google Scholar
• Snaith R. P., Mehta S., Raby A. N. Serum folate and vitamin B12 in epileptics with and without mental illness. British Journal of Psychiatry 1970; 116: 179–183
   Google Scholar
• Snaith R. P., McCourbie M. Antihypertensive drugs and depression. Psychological Medicine 1974; 4: 393–398
   Google Scholar
• Sortland O., Lundervold A., Nisbakken R. Mental confusion and epileptic seizures after cervical myelography with metrizamide. Acta Radiologica 1977; 403–406, Supplement 355
   Google Scholar
• Stein R. Hallucinations after sudden withdrawal of baclofen. Lancet 1977; 2: 1381
   Google Scholar
• Steinert J., Pugh C. R. Two patients with schizophrenia-like psychoses after treatment with beta-adrenergic agents. British Medical Journal 1979; 1: 799
   Google Scholar
• Stephens D. A. Psychotoxic effects of benzhexol. British Journal of Psychiatry 1967; 113: 213–218
   PubMed Web of Science ®Google Scholar
• Swash M., Roberts A. H., Zakho H., Heathfield K. W. G. Treatment of involuntary movement disorders with tetrabenazine. Journal of Neurology, Neurosurgery and Psychiatry 1972; 35: 186–191
   PubMedGoogle Scholar
• Taylor M., Galloway D. B., Petrie J. C., Davidson J. F., Gallon S. C., Moir D. C. Psychomimetic effects of pentazocine. British Medical Journal 1978; 2: 1198
   PubMedGoogle Scholar
• Toglia J. W., McGlamery M., Sanbandham R. R. Tetrabenazine in the treatment of Huntington's chorea and other hyperkinetic movement disorders. Journal of Clinical Psychiatry 1978; 39: 81–87
   Google Scholar
• Thompson M. K. Schizophrenia-like psychosis after treatment with beta-blockers. British Medical Journal 1979; 1: 1084–1085
   Google Scholar
• Thompson M., Perry J. S. Further experience with indomethacin in the treatment of rheumatic disease. British Medical Journal 1966; 1: 80–83
   PubMed Web of Science ®Google Scholar
• Thornton W. E. Dementia induced by methyldopa with haloperidol. New England Journal of Medicine 1976; 294: 1222
   Google Scholar
• Topliss D., Bond R. Acute brain syndrome after propranolol. Lancet 1977; tex2: 1133
   Google Scholar
• Trimble M. R., Reynolds E. H. Anticonvulsant drugs and mental symptoms. Psychological Medicine 1976; 6: 169–178
   PubMed Web of Science ®Google Scholar
• Van Praag H. M. Psychotropic drugs. McMillan Press, London 1978
   Google Scholar
• Verbist L., Pignot J., Cosemans A. Tolerance of ethionamide and PAS in original treatment of tuberculous patients. Scandinavian Journal of Respiratory Disease 1966; 47: 225–235
   Google Scholar
• Waal H. J. Propranolol-induced depression. British Medical Journal 1967; 2: 50
   PubMedGoogle Scholar
• Wallach M. B., Gershon S. Psychiatric sequelae to tuberculosis therapy. Psychiatric Complications of Medical Drugs, R. I. Shader. Raven Press, New York 1972; 201–202
   Google Scholar
• Weinberger D. R., Kelly M. J. Catatonia and malignant syndrome: a possible complication of neuroleptic administration. Journal of Nervous and Mental Disease 1977; 165: 263–268
   PubMed Web of Science ®Google Scholar
• Whitlock F. A. The syndrome of barbiturate dependence. Medical Journal of Australia 1970; 2: 391–396
   PubMed Web of Science ®Google Scholar
• Whitlock F. A., Bonfield A. R. Propranolol psychosis. Medical Journal of Australia 1980; 1: 184–185
   Google Scholar
• Whitlock F. A., Evans L. E. J. Drugs and depression. Drugs 1978; 15: 53–71
   PubMedGoogle Scholar
• Whitlock F. A., Fama P. G. Hyoscine poisoning in psychiatric patients. Medical Journal of Australia 1966; 2: 763–764
   Google Scholar
• Whitlock F. A., Nadorfi M. I. Diethylpropion and psychosis. Medical Journal of Australia 1970; 2: 1097
   PubMedGoogle Scholar
• Winokur A., Rickels K., Greenblatt E. J. Withdrawal reaction from long-term low dosage administration of diazepam. Archives of General Psychiatry 1980; 37: 101–105
   PubMed Web of Science ®Google Scholar
• Wood L. A., Moir D. C., Campbell C., Davidson J. F., Gallon S. C., Henney E., McAllion S. Medicine evaluation monitoring group; central nervous system effects of pentazocine. British Medical Journal 1974; 1: 305–307
   Google Scholar
• Woody G. E., O'Brien C. P., Greenstein R. Misuse and abuse of diazepam: an increasingly common medical problem. International Journal of Addictions 1975; 10: 843–848
   PubMed Web of Science ®Google Scholar